Keng-Li Lan

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Yuan‐Hung Wu · 3 shared papers, 2024–2026 · strength 0.68
   • Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
   • Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
   • Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084↗
2. Chung‐Pin Li · 3 shared papers, 2024–2026 · strength 0.68
   • Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
   • Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
   • Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084↗
3. Nai‐Jung Chiang · 2 shared papers, 2026 · strength 0.49
   • Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
   • Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
4. I‐Chun Lai · 2 shared papers, 2026 · strength 0.49
   • Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
   • Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
5. Yu‐Wen Hu · 2 shared papers, 2024–2026 · strength 0.42
   • Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
   • Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084↗
6. I‐Wei Ho · 1 shared paper, 2026 · strength 0.26
   • Paper Concurrent Systemic Therapy Intensity and Metabolic Response in Carbon-Ion Radiation Therapy for Locally Advanced Pancr… DOI 10.1016/j.ijrobp.2026.09.005↗
7. Hung-Yuan Yu · 1 shared paper, 2026 · strength 0.23
   • Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
8. Minghuang Chen · 1 shared paper, 2026 · strength 0.23
   • Paper Carbon ion therapy for pancreatic cancer with risk-adapted dose escalation: initial clinical experience. DOI 10.1016/j.radonc.2025.111238↗
9. Shih‐Ming Hsu · 1 shared paper, 2024 · strength 0.19
   • Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084↗
10. Fei‐Ting Hsu · 1 shared paper, 2022 · strength 0.16
    • Paper Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancre… DOI 10.1111/jcmm.17220↗
11. Yee Chao · 1 shared paper, 2022 · strength 0.16
    • Paper Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancre… DOI 10.1111/jcmm.17220↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.